Low-Dose Atropine

As of November 1, OSRX can compound Atropine+, a new customized medication, for your patients. We believe Atropine+ is substitutable because it combines low-dose atropine (0.01%, 0.025% and 0.05%) with a soothing lubricant and 50% less BAK preservative (0.005%), however, should you wish to continue prescribing the current Atropine formulation instead, please contact us. 

Our pricing for Atropine+ remains the same as Atropine. If you agree with this substitution, there will not be any interruptions to scheduled refills, and no further action is required for your patients to begin receiving Atropine+ on November 1, 2022. 

Questions? Contact your rep here.

FREQUENTLY ASKED QUESTIONS

What is Atropine+?
Atropine+ is a customized medication that combines low-dose atropine with a soothing lubricant and 50% less BAK (now 0.005%) – all for the same affordable price as our current Atropine medications.

Will the pricing change?
No. Your patients’ current pricing will remain the same. 

Will the bottle or label look different to my patient?
The Atropine+ bottle cap colors will remain the same, however you’ll notice a subtle design change to the label.

Will the prescribing process change?
No. You may submit patient-specific prescriptions for Atropine+ using your eRx system or the HIPAA-compliant OSRX Prescriber Portal.

Will I need to submit new prescriptions for patients with an active prescription and refills for Atropine?  
No. No action is required for patients to continue receiving their prescriptions. Should you wish to opt out of prescribing Atropine+, please contact us. 

Do I need to complete a NEW account form to prescribe Atropine+? 

• Are you a current prescriber? If so, no. Please note that we believe Atropine+ is substitutable because it combines low-dose atropine with a soothing lubricant and 50% less BAK. Should you wish to opt out of prescribing this new medication, please contact us.  
• Are you a NEW prescriber? If so, yes. Please fill out a new account inquiry form here and a representative will contact you shortly.

---

Professional Disclosure: Dr. Tsang has a financial interest in Ocular Science^® (an affiliate of OSRX).

OSRX medications carry serious risks. Please click here to view potential adverse events and contraindications.

*For professional use only. OSRX specializes in customizing compounded medications to meet unique patient and practitioner needs. Compounded drugs are not FDA-approved, which means they have not undergone FDA premarket review for safety, effectiveness, and quality.